StockMarketWire.com - Creo Medical Group announced Monday that the Hospital Universitario Virgin del Rocio de Sevilla had treated the first patient in mainland Europe using the company's Speedboat device.

The patient, with a large pre-cancerous lesion in the lower gastrointestinal tract, was treated by 'leading Spanish gastrointestinal surgeon, Dr. Francisco J. Garcia Fernandez, at the Hospital Universitario Virgin del Rocio de Sevilla,' Creo said.

Dr Fernandez would provide ongoing clinical training for endoscopists in Spain as part of the market seeding and training framework distribution agreement with Spanish distributor, JJP Hospitalaria SL.

'It was a pleasure to watch Dr Fernandez perform this complex procedure and utilise the technology and techniques we have established through the Creo Medical Clinical Education Programme, said Simon Meadowcroft, Director of Emerging Technology at Creo.

'This was a complicated case that enabled the patient to avoid more invasive surgery and the risks and complications associated with it. It's great to see the advances in therapeutic endoscopy that our advanced energy platform is enabling and the difference this makes to patient outcomes.'


At 9:32am: [LON:CREO] Creo Medical Group Plc share price was +9p at 187p



Story provided by StockMarketWire.com